EX-10.11 14 a2238954zex-10_11.htm EX-10.11 Execution Version Amendment Agreement No. 1 dated as of November 21, 2018 by and between Infront Holding AG (IHAG, Parent, Guarantor or Security Provider) Infront Sports & Media AG (ISMAG, Company, Borrower,...Amendment Agreement No. 1 • May 5th, 2020
(IIHAG, IHAG, ISMAG, Infront Pan-Asia, Infront Italy Holding, Infront Italy, HOST BROADCAST and Infront Football, collectively, the Infront Parties, and, together with UBS, the the Parties)
Amendment Agreement No. 1 dated September 5, 2007 among:Amendment Agreement No. 1 • March 31st, 2009 • Lifetime Brands, Inc • Cutlery, handtools & general hardware
RECITALSAmendment Agreement No. 1 • April 4th, 2000 • Lithium Technology Corp • Miscellaneous electrical machinery, equipment & supplies
AMENDMENT AGREEMENT NO. 1Amendment Agreement No. 1 • November 23rd, 2009 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS AMENDMENT AGREEMENT NO. 1 (the “Amendment Agreement”) is made as of the 20th day of November, 2009, by and between Kingsbridge Capital Limited, an entity organized and existing under the laws of the British Virgin Islands, whose registered address is Palm Grove House, 2nd Floor, Road Town, Tortola, British Virgin Islands (the “Investor”), and Jazz Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in that certain Common Stock Purchase Agreement, dated as of May 7, 2008, by and between the Investor and the Company (the “Purchase Agreement”).
ContractAmendment Agreement No. 1 • March 20th, 2019
AMENDMENT AGREEMENT NO. 1 D ODATEK KE SMLOUVĚ Č. 1 THIS AMENDMENT AGREEMENT NO. 1 ismade effective as of its publication in the Register of Agreements (the “Effective Date”), but the Parties agreed to be bound by the rights and obligations contained in this Amendment Agreement No. 1 from the date of the site initiation visit at site TENTO DODATEK KE SMLOUVĚ Č. 1 nabýváúčinnosti ke dni jeho uveřejnění v registru smluv (dále jen „Datum účinnosti“), avšak Smluvní strany se dohodly, že budou vázány úpravou práv a povinností obsaženou v tomto Dodatku ke Smlouvě č. 1 již od iniciační vizity Studie na centru “AMONG” „MEZI“ (1) Biogen Idec Research Limited, located at Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, United Kingdom (“Biogen”); (1) společností Biogen Idec Research Limited, se sídlem v Innovation House, 70, Norden Road, Maidenhead, Berkshire, SL6 4AY, Spojené království (dále „Biogen“); (2) Fakultní nemocnice Brno, located at Jihlavská 20, 625 00 Brno, Czech Repu
